Patent ID: 6103754
Filing Date: 2000-08-15
Classification: A61P,C07C,C07D,Y02P

Abstract:
A method of treating diseases caused by degeneration of central or peripheral nervous system, comprising: administering to a patient an effective amount of a nerve growth factor activity potentiating compound, wherein the improvement comprises, as said nerve growth factor activity potentiating compound, a 1,2-ethanediol derivative represented by the following formula or its salt: ##STR41## wherein R.sup.1 represents a substituted or unsubstituted heterocyclic group; R.sup.2 represents a hydrogen atom, a lower alkyl group or a hydroxyl-protecting group; R.sup.3 represents a hydrogen atom or a lower alkyl group; nR.sup.4 's may be the same as or different from one another and each represents a hydrogen atom or a lower alkyl group; nR.sup.5 ;s may be the same as or different from one another and each represents a hydrogen atom or a lower alkyl group; R.sup.6 represents a substituted or unsubstituted amino or an ammonium group; and n represents an integer of 1 to 6.